Observational studyScientific reports2025
A 7-year experience in adenoidectomy with endoscopic radiofrequency volume reduction.
Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the effectiveness, safety, and postoperative outcomes of endoscopic radiofrequency adenoidectomy in pediatric patients over seven years. This study was conducted at the University Hospitals between May 2017 and August 2024. This prospective observational case series included pediatric patients who underwent endoscopic radiofrequency adenoidectomy due to adenoid hypertrophy and related complications. Preoperative evaluation included clinical assessment, nasal endoscopy, and imaging. Intraoperative data, including blood loss and operative time, and postoperative outcomes, such as pain, bleeding, and halitosis, were recorded. The mean operative time was 15 min, and the mean blood loss was 31 ml (p = 0.0001). Postoperative pain decreased significantly over time (p = 0.0001). Primary bleeding occurred in 0.3% of cases. Halitosis affected 2% of patients during the first week but was reduced by the first month (p = 0.0001). Endoscopic radiofrequency adenoidectomy is a safe, efficient, and minimally invasive approach for managing adenoid hypertrophy in pediatric patients. It offers minimal blood loss, rapid recovery, and low complication rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.